Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
85 participants
INTERVENTIONAL
2017-02-14
2023-03-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy Study for Development and Use of Neurofeedback-trainings for Patients Suffering From Chronic Tinnitus
NCT02383147
Neuro-feedback Therapy for Treating Tinnitus
NCT03773926
Research Project About Psychological Strain, Quality of Life and Emotional Awareness in Patients With Tinnitus
NCT01837368
ICCAC-ToNF & Tinnitus
NCT03895047
Exploring the Links Between Hearing, Cognition and Brain Activity in People With Tinnitus
NCT06940726
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The main goal of this project is to comparatively assess tinnitus reduction using neurofeedback (fMRI or EEG) compared to cognitive behavioral therapy in participants with chronic severe tinnitus.
* The participants are assigned to 3 different experimental groups (EEG neurofeedback, fMRI neurofeedback, or cognitive behavioral therapy). The participation per subject will last from 4 to 12 months.
* The participants undergo medical tests including audiological tests as well as questionnaires related to tinnitus and quality of life at different timepoints of the study (pre and post training visits).
* At the end of the experimental visits, each participant will have one early and one late post-assessment evaluation visits.
* In order to evaluate the longer-term evolution of tinnitus over time, long-term follow-ups will be scheduled starting at 9 months after the final experimental visit, and will occur every 4.5 months thereafter, until research ends (for a maximum of 5 years).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
fMRI Neurofeedback
The participants receive visual feedback (displayed on a screen) related to BOLD activity from their auditory cortices, and they are asked to learn to down-regulate it.
fMRI Neurofeedback
15 intervention sessions on a 3T MRI scanner.
EEG Neurofeedback
The participants receive visual feedback (displayed on a screen) related to the ratio of alpha to delta localized activity from their auditory cortices, and they are asked to learn to up-regulate it.
EEG Neurofeedback
15 intervention sessions with a standard EEG-cap with 64 active electrodes.
Cognitive Behavioral Therapy
Group therapy is provided by trained clinicians for research participants. Participants are confronted with tinnitus-inducting situations and trained to use diverse cognitive and behavioral coping skills to reduce the subjective impact of tinnitus burden. Such coping skills include relaxation, distraction, and de-catastrophizing, among other strategies.
Cognitive Behavioral Therapy
10 intervention sessions of CBT group therapy, as per local university hospital standard of care.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
fMRI Neurofeedback
15 intervention sessions on a 3T MRI scanner.
EEG Neurofeedback
15 intervention sessions with a standard EEG-cap with 64 active electrodes.
Cognitive Behavioral Therapy
10 intervention sessions of CBT group therapy, as per local university hospital standard of care.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Tinnitus Handicap Inventory ≥ 48
3. Chronic, persistent, non-pulsatile tinnitus for minimum 6 months
4. Functional hearing
5. Normal inner ear structure assessment using an ear microscope, normal tympanic membrane mobility
6. Participant willing, able and available to participate in the entire research, including completion of questionnaires and traveling to research sites for the duration of the trial
Exclusion Criteria
2. Conductive hearing loss exceeding 20 dB at two or more frequencies
3. Known diagnoses causing tinnitus or hearing loss:
* Known systemic disease (vestibular schwannoma, endolymphatic hydrops)
* Lesion in central nervous system, including history of severe cranio-cerebral trauma
* Acute ear canal or middle ear inflammation or effusion
4. Significant neurologic disease, psychiatric disease, substance abuse or acute allergic disease
5. Ongoing medication that is known to treat, influence, or cause tinnitus (e.g. high-dose aspirin, quinidine, aminoglycosides)
6. Ongoing or recent (completed since less than 4 weeks) tinnitus therapy (e.g. tinnitus maskers, acupuncture)
7. Participation in competitive or pharmacological study
8. Pregnant woman
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ecole Polytechnique Fédérale de Lausanne
OTHER
Wyss Center for Bio and Neuroengineering
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pascal Senn, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Dept. of Otology, Audiology and Cochlear Implant Surgery, University Hospital Geneva
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dept. of Otology, Audiology and Cochlear Implant Surgery, University Hospital Geneva
Geneva, Canton of Geneva, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Gninenko N, Trznadel S, Daskalou D, Gramatica L, Vanoy J, Voruz F, Robyn CL, Spadazzi A, Yulzari A, Sitaram R, Van De Ville D, Senn P, Haller S. Functional MRI Neurofeedback Outperforms Cognitive Behavioral Therapy for Reducing Tinnitus Distress: A Prospective Randomized Clinical Trial. Radiology. 2024 Feb;310(2):e231143. doi: 10.1148/radiol.231143.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NeuroTin
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.